NIH-funded research R01 grant

How cells detect changes in enzyme activity

Official title: A novel and simple mechanism by which cells can sense enzymatic flux

Funded at Harvard Medical School · NIH-10983304 · Data updated 2026-11-12

This study is looking at how yeast cells detect and respond to the way they use nutrients, specifically focusing on how they process galactose, which could help us understand how metabolism works in different living things.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 1, 2023
Project endNovember 30, 2026
Funding year2025
Award (this year)$315,388
NIH project number5R01GM148497-03
Project IDNIH-10983304 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with metabolic disorders or conditions related to enzyme activity.

Less likely to help

Patients with unrelated health issues or those not affected by metabolic disorders may not benefit from this research.

What this research studies

This research investigates how cells sense the activity of enzymes that process nutrients, focusing on a specific pathway in yeast. By studying the galactose utilization pathway, the researchers aim to uncover a straightforward mechanism that allows cells to measure metabolic flux, which is the flow of nutrients through metabolic pathways. The approach involves using advanced quantitative measurements and computational modeling to analyze and interpret the data collected from experiments. This could lead to a better understanding of metabolic regulation in various organisms.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of metabolic processes, potentially leading to new treatments for metabolic disorders and cancers.

How similar studies have gone: Other research has shown success in understanding metabolic pathways, but this specific mechanism is novel and has not been extensively tested.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Springer, Michael — Harvard Medical School
  • Study coordinator: Springer, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.